#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19418	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1996	953.6	0	.	n	.	0	C451T	SNP	451	451	C	669	669	T	1103	T,C	597,477	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19418	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1996	953.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1402	1402	C	1117	C	1080	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19418	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1996	953.6	0	HET	.	.	.	C207T,A	.	207	207	C	425	425	C	1060	C,T,A	803,204,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35402	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	1004.3	0	.	n	.	0	T695C	SNP	695	695	T	1029	1029	C	1107	C,G	1065,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35402	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	1004.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	1024	C	1002	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35402	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	1004.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	1057	A	1024	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35402	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	1004.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	1055	C,T,G	1015,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2284	folP	855	855	100.0	folP.l15.c4.ctg.1	1574	142.6	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	216;217;217	A;G;C	213;214;212	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6096	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	177.6	1	SNP	p	S91F	1	.	.	271	273	TTC	628	630	TTC	203;205;207	T;T;C	198;199;199	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6096	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	177.6	1	SNP	p	G95N	0	.	.	283	285	GGC	640	642	GGC	206;203;200	G;G,T;C	202;197,1;197	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6096	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	177.6	1	SNP	p	D95G	1	.	.	283	285	GGC	640	642	GGC	206;203;200	G;G,T;C	202;197,1;197	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2112	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1255	166.5	1	SNP	p	G45D	0	.	.	133	135	GGC	469	471	GGC	256;259;257	G;G;C	250;252;250	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	958	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1018	92.6	0	.	n	.	0	A197.	DEL	197	197	A	609	609	A	206	A	198	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	227.0	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	282;284;287	G;A;C	276;274;281	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	227.0	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	289;290;292	C;G,A;T	284;283,1;286	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	227.0	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	289;290;292	C;G,A;T	284;283,1;286	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	227.0	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	289;290;292	C;G,A;T	284;283,1;286	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	227.0	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	292;289;288	T;C;C	282;283;283	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4890	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2744	176.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	238;234;234	G;G;C	228;225;221	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1210	1212	GCC	260;260;261	G;C;C,A	249;253;252,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1213	1215	ATG	260;258;260	A;T;G	252;248;251	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1225	1227	ACC	259;259;259	A;C;C,A	247;248;248,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1225	1227	ACC	259;259;259	A;C;C,A	247;248;248,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1726	1728	ACC	244;247;250	A;C;C	226;239;241	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1780	1782	GCG	242;241;245	G;C;G	233;234;232	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1780	1782	GCG	242;241;245	G;C;G	233;234;232	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1903	1905	GGT	182;183;181	G;G;T	177;178;170	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1912	1914	AGC	165;164;162	A;G;C	157;158;153	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	194.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1930	1932	CCG	127;129;125	C,G;C;G,T	116,1;119;107,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7552	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3010	247.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1640	1642	CCG	240;242;242	C;C;G,A	217;225;221,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3096	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1772	171.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	650	650	C	217	C,G	196,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3896	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1506	254.7	0	.	p	.	0	E209K	NONSYN	625	627	GAA	877	879	AAA	296;297;308	A;A;A	290;290;300	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3896	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1506	254.7	0	.	p	.	0	A212E	NONSYN	634	636	GCA	886	888	GAA	300;302;304	G;A;A	287;294;299	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3896	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1506	254.7	1	SNP	p	G120K	1	.	.	358	360	AAG	610	612	AAG	283;284;289	A;A;G	275;276;272	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3896	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1506	254.7	1	SNP	p	A121N	1	.	.	361	363	AAC	613	615	AAC	285;286;284	A;A;C	279;279;268	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3896	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1506	254.7	1	SNP	p	N121D	0	.	.	361	363	AAC	613	615	AAC	285;286;284	A;A;C	279;279;268	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13970	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4905	281.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1658	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	972	168.2	1	SNP	p	V57M	1	.	.	169	171	ATG	501	503	ATG	341;341;341	A;T;G,T	333;335;335,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
